Real-world Treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy: A Multinational, Pooled Analysis From the Ibrance Real World Insights Study

Mycock, K; Hanson, KA; Taylor-Stokes, G; Milligan, G; Atkinson, C; Mitra, D; Preciado, S; Law, EH

Mycock, K (通讯作者)，Adelphi Real World, Bollington, England.

CLINICAL THERAPEUTICS, 2022; 44 (12): 1588

Abstract

Purpose: Palbociclib was the first cyclin-dependent kinase 4/6 inhibitor approved by the US Food and Drug Administration for use in combination with a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索